In defense of basic science - my new video about how we balance basic vs. translational science: youtu.be/yl6ETxRfQn8?si=lEim…. . And why we should encourage a culture of wandering to solve problems:. A team effort between @UniofOxford and @OxfordSparks.

It was a privilege to reflect on the life and legacy of Greg Hannon in an obituary published in Cell, co-authored with Julius Brennecke. Collaborating on this was a gift: a chance to reminisce, remember, and try to capture what made Greg so extraordinary. bit.ly/4elZcAU

A fantastic new #zebrafish model of uveal #melanoma from the lab of @TheKennyLab. This demonstrates the power of modeling rare but difficult to treat cancers, opening up new avenues to understand the biology and find new treatments. It has been really nice seeing this story evolve and congrats on this beautiful work: aacrjournals.org/cancerres/a…

We are looking for a motivated Post-doctoral scholar to really push the envelope in metabolic imaging. Come join our group at MSK! linkedin.com/posts/kayvan-r-…

Today the melanoma community mourns the loss of Professor Richard Scolyer, AO, a pioneering melanoma pathologist, visionary researcher, and dedicated champion for patients. Dr. Scolyer, one of the world’s foremost melanoma pathologists and global leader in bridging laboratory science with patient care, transformed how melanoma is diagnosed and staged and helped set international standards that assist how clinicians care for patients around the globe. MRA was honored to support Dr. Scolyer and his team at the Melanoma Institute Australia through a 2020 Team Science Award focused on improving outcomes for patients with high-risk in-transit melanoma. Their work generated important insights into treatment resistance, predictive biomarkers, and personalized treatment strategies. After his own glioblastoma diagnosis, Dr. Scolyer remained dedicated to advancing science, courageously helping to pioneer new treatment approaches that may benefit future patients. We extend our deepest condolences to Dr. Scolyer's family, friends, colleagues, and the entire Melanoma Institute Australia community. MRA is proud to have been part of his remarkable journey and will continue to honor his legacy by supporting the bold, collaborative research he championed throughout his career.

An Australian cancer researcher who helped develop a treatment for melanoma before using a similar approach to tackle his own incurable brain cancer has died aged 59 timeshighereducation.com/new…

Pioneering Australian doctor Richard Scolyer dies after brain cancer battle bbc.in/4ulquxe

Finally out in @Cellcellpress! Proteins with long intrinsically disordered regions (IDRs) are prone to misfolding during protein synthesis. This is prevented by mRNA 3′UTRs that act as mRNA-based IDR chaperones. cell.com/cell/fulltext/S0092…

Great environment to do creative and cutting edge systems/synthetic biology - highly encourage you to apply.

It is with a heavy heart that we share the deeply sad news that our cherished colleague Prof Richard Scolyer AO passed away yesterday 7th June 2026. Richard was a renowned pathologist and a world authority on skin cancer and melanoma diagnoses. His broad knowledge of and passion for pathology, along with his generous mentorship and teaching, have inspired many and transformed melanoma and skin cancer research and diagnosis across the globe. Richard was an integral and esteemed part of Melanoma Institute Australia (MIA) and the melanoma community for over two decades. His commitment to and advocacy for his profession, coupled with his enthusiasm for life and his genuine humanity, resonated broadly, and has left a lasting positive impact. “I am deeply saddened to lose such a cherished colleague. Richard was a truly extraordinary pathologist - the 'pathologists' pathologist' - who also made generous time for clinicians navigating complex diagnostic cases, understanding that an accurate tissue diagnosis was critical to patient care. His knowledge was vast, his skill exceptional, with an unparalleled eye for accurate tissue diagnoses, and the precision to apply decades of experience where it mattered most.” “He shared his expertise widely: through consultation on external specimens, through diagnostic and classification frameworks now used worldwide, and as a devoted teacher and mentor. Richard has left an indelible mark on all who had the privilege of working alongside him.”  - Professor Georgina Long MIA is proud to have instituted the Richard Scolyer Pathology Fellowship, honouring Richard's legacy, and his commitment to shaping the next generation of melanoma pathologists. Our thoughts are with Richard's family during this difficult time, especially his wife Katie and children Emily, Matthew, and Lucy. As we mourn the passing of Richard, we also reflect on a remarkable life that touched so many. Please consider sharing a tribute message for Richard on our MIA website> bit.ly/4uncLpx Richard's legacy will live on, continuing to inspire us all, as we continue working toward our vision of zero deaths from melanoma.

Richard's death is a a loss to our entire community - a humanitarian, clinician, scientist and patient.

The truest highlight of any academic career is seeing trainees find their own path. One of my former postdocs @shruthy_suresh is such a passionate scientist, and her institute just made a profile about her and the work she is doing on cancer metastasis. She is so inspiring - check it out: x.com/IGIBSocial/status/2057…

The annual Zebrafish Disease Models Society meeting is in Oxford this year - we already have a great lineup of new speakers, covering lots of different diseases and technologies. Registration and abstracts closing soon! @ZDMSociety #zebrafish. Check it out here: lnkd.in/e7w-dQ-K

An exciting EMBO regeneration meeting coming up in September! Check out the program and details about registration here: meetings.embo.org/event/26-t…. #EMBORegeneration2026

My department at Oxford is recruiting junior faculty to the Ludwig Institute for Cancer Research. A collaborative and stimulating department, with great access to the breadth of the Oxford environment. The positions come with core funding and cutting edge technologies. If interested, apply here: shorturl.at/1ggGt

Our new Comment is out today in @natrevbioeng. mRNA could treat many more diseases than it currently does, but we don’t have a way to get it to most of the cells where it’s needed. We explain why a cell will be the next transformative delivery vehicle⬇️

The @acmedsci Professorship Scheme is now open. This generous grant allowed me to explore new and "out there" ideas without restrictions. A new round is open offering up to £500k to researchers moving to the UK for a full Professorship. If you're eligible, highly encourage you to apply: bit.ly/4tTaN0u

New paper: Bosch, J. A. et al. (2026) Multi-omic mapping of Drosophila protein secretomes reveals tissue-specific origins and inter-organ trafficking. Nat Commun. doi: 10.1038/s41467-026-71763-8. PMID: 42009678

For a long time, I assumed we mammals weren't all that regenerative. Then I learned that we can regenerate our digit tips! In @MekaylaStorer new paper they show why and how. Check it out: science.org/doi/10.1126/scie…

A great preview by Ben and Joanna on our paper where endogenous DNA damage induced stem cell extinction is enough to lead to clonal hematopoiesis👋

Interesting idea - clonal outgrowth by stem cell "attrition" rather than selection for DNA drivers. Suspect this could apply to many different situations, not just clonal hematopoiesis. Congrats to the team.